ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2011

Should the presence of germline BRCA1/2 mutations influence treatment selection in breast cancer?

Mark E RobsonPubMed ↗Publisher ↗

No numbers read from the abstract.